Collectively, these data confirmed that ADAR2 expression was inhibited in NAFLD and could be induced by exercise, which was associated with hepatic lipid accumulation suggesting a role of ADAR2 in lipid metabolism. The gene discussed is ADARB1; the disease is metabolic dysfunction-associated steatotic liver disease.